XML 32 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Significant Accounting Policies (Details Textual) - shares
 9 Months Ended
Jul. 08, 2020
Sep. 30, 2020
Significant Accounting Policies (Textual)    
Contingent obligation payment percentage   37.00%
Bonus agreements percentage   80.00%
Cash dividends received   80.00%
Fair value hierarchy inputs, description   The Company has determined that the inputs used in measuring the fair value of the contingent payment obligation fall within Level 3 in the fair value hierarchy which involves significant estimations and assumptions regarding any projected future proceeds from the LO2A, including, among others, the dry eye US market size in 2025 (USD 2.9 Billion), the maximum penetration rate of the product into the U.S. market - 12%, the patent expiration date (2038), the operational profit rate - 26%, the probabilities for FDA phases approvals, and the risk-adjusted rate for discounting future cash flows - 20.3%.
Series B Preferred Stock [Member]    
Significant Accounting Policies (Textual)    
Number of bonus shares distributed by company 68,191,200  
Redeem Series B Preferred Stock, description However, as of September 30, 2020, an amount of 9,546,768 Bonus Shares (out of the said 68,191,200 shares) to which several of the former holders of Series B Preferred Stock are entitled, are still held in the Company's bank account as the Company did not receive the required instructions as to the transfer of such Bonus Shares from such former holders. The said shares are presented in the balance sheet as an asset and a liability at the amount of $1,007.